Biosite Triage Panel For Drugs Of Abuse (50NG/ML)
510(k) K931598
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK931598 | Date12 May 1993 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- LDJ
- Device Class
- Class II
- Regulation
- 21 CFR Part 862.3870
- Advisory Committee
- Clinical Toxicology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 27 Sep 2026
The Biosite Triage Panel For Drugs Of Abuse is an enzyme immunoassay device used for the qualitative determination of parent compounds and/or major metabolites of up to nine distinct drug classes in urine samples. This device is classified as a Class II medical device and is intended for clinical toxicology applications. The panel provides a screening method for detecting various drug substances in urine specimens.
The device is supplied as a single-use panel and requires appropriate storage conditions as specified by the manufacturer. It received FDA 510(k) clearance with number K931598 on May 12, 1993, and is manufactured by Biosite Incorporated in San Diego, California. The device is not indicated for MRI safety and should be used according to the manufacturer's instructions for proper handling and interpretation of results.